Pages that link to "Q36949179"

The following pages link to Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort (Q36949179):

Displaying 14 items.

• Patterns of colorectal cancer care in the United States and Canada: a systematic review (Q26863029) (← links)
• G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use. (Q34982532) (← links)
• Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer (Q36479390) (← links)
• Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort (Q38641700) (← links)
• The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia (Q39175238) (← links)
• Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy (Q39785729) (← links)
• Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer (Q40810746) (← links)
• Increasing utilization and predictors of hematopoietic growth factors in patients diagnosed with colorectal cancer: findings from a large national population-based cohort in the USA, 1992-2009. (Q41735144) (← links)
• Comparative Effectiveness of White Blood Cell Growth Factors on Neutropenia, Infection, and Survival in Older People with Non‐Hodgkin's Lymphoma Treated with Chemotherapy (Q43573720) (← links)
• Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin's lymphoma (Q44395288) (← links)
• Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer (Q45847822) (← links)
• Effect of Primary Prophylactic Granulocyte-Colony Stimulating Factor Use on Incidence of Neutropenia Hospitalizations for Elderly Early-stage Breast Cancer Patients Receiving Chemotherapy (Q46798775) (← links)
• Medication overuse in oncology: current trends and future implications for patients and society. (Q52610761) (← links)
• Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy (Q87225398) (← links)